Yusuke Higuchi Selected Research

Drug Therapy (Chemotherapy)

1/2022	Beneficial impact of first-line mogamulizumab-containing chemotherapy in adult T-cell leukaemia-lymphoma.
8/2016	Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy.
1/2015	Rituximab Monotherapy and Rituximab-Containing Chemotherapy Were Effective for Paraneoplastic Pemphigus Accompanying Follicular Lymphoma, but not for Subsequent Bronchiolitis Obliterans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yusuke Higuchi Research Topics

Disease

8	Neoplasms (Cancer) 01/2023 - 04/2016
4	Fibrosis (Cirrhosis) 01/2024 - 01/2011
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2023 - 01/2015
4	Chronic Renal Insufficiency 12/2017 - 12/2010
3	COVID-19 03/2023 - 01/2023
3	Infections 03/2023 - 01/2022
2	Pulmonary Hypertension 01/2024 - 06/2023
2	Heart Failure 10/2023 - 12/2017
2	Lymphoma (Lymphomas) 09/2023 - 01/2022
2	Hypoxia (Hypoxemia) 06/2023 - 01/2022
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2022 - 01/2021
2	Infarction (Infarctions) 01/2022 - 01/2019
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 01/2017
2	Inflammation (Inflammations) 01/2020 - 06/2013
2	Myeloid Leukemia (Leukemia, Myelocytic) 08/2016 - 03/2011
2	Atherosclerosis 06/2013 - 12/2010
1	Cognitive Dysfunction 01/2024
1	Alzheimer Disease (Alzheimer's Disease) 01/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024
1	Disease Progression 11/2023
1	Hemorrhagic Shock 11/2023
1	Multiple Myeloma 09/2023
1	Febrile Neutropenia 09/2023
1	Fatty Liver 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Hepatitis 01/2023
1	Reperfusion Injury 01/2022
1	Edema (Dropsy) 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Hypothermia 01/2022
1	Obesity 01/2022
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019
1	Diabetes Mellitus 12/2017
1	Starvation 12/2017
1	Intestinal Volvulus (Volvulus) 10/2017
1	Hodgkin Disease (Hodgkin's Disease) 05/2017
1	Bone Fractures (Bone Fracture) 10/2016

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2011
3	IndicanIBA 06/2013 - 12/2010
2	CateninsIBA 01/2024 - 01/2024
2	ICG 001IBA 01/2024 - 01/2024
2	Monoclonal AntibodiesIBA 03/2023 - 01/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 12/2017
2	mogamulizumabIBA 01/2022 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2014
2	14-3-3 Proteins (14-3-3 Protein)IBA 01/2018 - 04/2016
2	Rituximab (Mabthera)FDA Link 08/2016 - 01/2015
1	Caveolin 1IBA 01/2024
1	beta CateninIBA 01/2024
1	ProdrugsIBA 01/2024
1	Messenger RNA (mRNA)IBA 10/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2023
1	Cefepime (Maxipime)FDA LinkGeneric 09/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 03/2023
1	cilgavimabIBA 01/2023
1	Digoxin (Digitek)FDA LinkGeneric 01/2023
1	tixagevimabIBA 01/2023
1	AerosolsIBA 01/2023
1	AlpelisibIBA 01/2023
1	fusicoccinIBA 01/2023
1	InterferonsIBA 01/2023
1	LipidsIBA 01/2023
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 05/2022
1	2-methylthiazolineIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	ParaffinIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	TroponinIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	polatuzumab vedotinIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	CytokinesIBA 01/2020
1	Early Growth Response Protein 1IBA 01/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	KetonesIBA 12/2017
1	Histones (Histone)IBA 12/2017
1	IsotopesIBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	CalciumIBA 12/2017
1	BariumIBA 10/2017
1	Brentuximab VedotinIBA 05/2017
1	NivolumabIBA 05/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Gemcitabine FDA Link 01/2017
1	Guanosine Diphosphate (GDP)IBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	MagnesiumIBA 10/2016

Therapy/Procedure

8	Therapeutics 11/2023 - 01/2014
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
2	Salvage Therapy 01/2017 - 01/2015
1	Cardiopulmonary Resuscitation (CPR) 11/2023
1	Induced Hypothermia 01/2022